U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07441109) titled 'Shatavari Root Extract for Perimenopausal Symptoms' on Feb. 23.
Brief Summary: This randomized, double-blind, placebo-controlled clinical study evaluates the efficacy and safety of a standardized Shatavari (Asparagus racemosus) root extract in women experiencing perimenopausal symptoms. Participants will receive either Shatavari root extract or a matched placebo for 12 weeks. Efficacy will be assessed using validated menopause-specific symptom, quality-of-life, stress, mood, and sleep questionnaires, along with physiological stress markers. Safety will be evaluated through laboratory assessments and adverse event monitoring.
Study ...